Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2 and prostate carcinogenesis.

Tajamul Hussain1, Sanjay Gupta, Hasan Mukhtar

  • 1Department of Dermatology, University of Wisconsin, Medical Science Center, 1300 University Avenue, Madison, WI 53706, USA.

Cancer Letters
|March 6, 2003
PubMed
Summary

Cyclooxygenase-2 (COX-2) is overexpressed in human prostate cancer, suggesting its role in cancer development. Selective COX-2 inhibitors may offer chemopreventive and chemotherapeutic benefits for prostate cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use and Outcomes of Vascular Access in Complicated Paediatric Appendicitis - A Multicentre Prospective Observational Study.

Journal of pediatric surgery·2025
Same author

Photochemoprevention of ultraviolet Beam Radiation-induced DNA damage in keratinocytes by topical delivery of nanoformulated Epigallocatechin-3-gallate.

Nanomedicine : nanotechnology, biology, and medicine·2022
Same author

Multi-ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy.

Cancer reports (Hoboken, N.J.)·2021
Same author

Tissue microarray profiling and integrative proteomics indicate the modulatory potential of Maytenus royleanus in inhibition of overexpressed TPD52 in prostate cancers.

Scientific reports·2021
Same author

Epigenetic regulation of RNA sensors: Sentinels of immune response.

Seminars in cancer biology·2021
Same author

African Vegetables (<i>Clerodendrum volibile</i> Leaf and <i>Irvingia gabonensis</i> Seed Extracts) Effectively Mitigate Trastuzumab-Induced Cardiotoxicity in Wistar Rats.

Oxidative medicine and cellular longevity·2020

Area of Science:

  • Oncology
  • Molecular Biology
  • Inflammation Research

Background:

  • Cyclooxygenase (COX) is a key enzyme in prostaglandin synthesis, with two isoforms: COX-1 and COX-2.
  • COX-1 is constitutively expressed for normal physiological functions, while COX-2 is pro-inflammatory and inducible.
  • COX-2 overexpression is observed in numerous human cancers and cell lines, implicating it in cancer development.

Purpose of the Study:

  • To investigate the role of cyclooxygenase-2 (COX-2) in prostate cancer development and progression.
  • To provide evidence for COX-2 overexpression in human prostate adenocarcinoma.
  • To explore the potential of COX-2 inhibitors in prostate cancer chemoprevention and therapy.

Main Methods:

  • Review of existing epidemiological studies and scientific literature on COX-2 and cancer.

Related Experiment Videos

  • Analysis of data from a recently published study on COX-2 expression in human prostate adenocarcinoma.
  • Comparison of COX-2 expression in cancerous prostate tissue versus normal tissue.

    • Main Results:

    • The study confirmed the initial observation of COX-2 overexpression in human prostate adenocarcinoma.
    • Subsequent studies verified elevated COX-2 levels in human prostate cancer compared to normal tissues.
    • Some research indicates COX-2 up-regulation in proliferative inflammatory atrophy, not necessarily carcinoma itself.

    Conclusions:

    • COX-2 is significantly overexpressed in human prostate cancer, supporting its role in carcinogenesis.
    • COX-2 inhibitors may exert chemopreventive effects by modulating COX-2 activity in prostate cells.
    • Selective COX-2 inhibitors hold promise for chemoprevention and chemotherapy in human prostate cancer.